By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Phoenix RelationsPhoenix RelationsPhoenix Relations
  • Home
  • Categories
    • CrimeUnlimited
    • Economy
    • Education
    • Entertainment
    • HealthHot
    • Exclusives
    • News100+
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • About
  • Privacy Policy
  • Contact Us
Reading:
Share
Sign In
Notification Show More
Font ResizerAa
Phoenix RelationsPhoenix Relations
Font ResizerAa
Search
  • Home
  • About Us
  • Blog
  • Categories
    • Crime
    • Economy
    • Education
    • Entertainment
    • Health
    • Exclusives
    • News
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • Contact
  • Privacy Policy
Have an existing account? Sign In
Follow US
  • Advertise
© 2024 Phoenix Relations. All Rights Reserved.
Default Blog

Phoenix Relations
Last updated: 13 January 2026 08:27
Phoenix Relations
Share
3 Min Read
SHARE

The National Agency for Food and Drug Administration and Control has alerted Nigerians on the recall of Mivacron and Nimbex injections over safety concerns.
‎
‎In a statement via X on Monday, the regulatory agency said the affected products were manufactured by Aspen Pharmacare Asia Limited, saying the recall followed safety concerns flagged by the Hong Kong Department of Health.
‎
‎NAFDAC said one batch of Mivacron Injection 0.2 per cent and five batches of Nimbex Injection 2mg/mL are affected by the recall.
‎
‎“The recall was made as a precautionary measure due to potential quality issues identified by the manufacturer,” NAFDAC said.

It said investigations revealed deficiencies in the manufacturer’s manual visual inspection process, adding that “not all glass particles in the ampoules were likely detected,” prompting a voluntary market recall.

The injections, containing mivacurium and cisatracurium, are prescription medicines used as adjuncts to general anaesthesia.
NAFDAC advised healthcare professionals and consumers to report suspected substandard medicines to its nearest office or via its e-reporting platforms (www.nafdac.gov.ng).
In another development, NAFDAC reassured Nigerians that all Nestlé infant formulae approved for sale in Nigeria are safe.
It stated that the infant formulae were not affected by the recent voluntary recall announced by Nestlé UK involving specific batches of SMA Infant Formula and Follow-On Formula in over 50 countries.
“NAFDAC clarifies that the recalled products are UK batches withdrawn as a precaution due to the potential presence of cereulide, a heat-resistant toxin produced by certain strains of Bacillus cereus, which may cause nausea and vomiting.
“These affected batches were not registered by NAFDAC and are not authorised for distribution in Nigeria,” it said in a statement signed by its Director-General, Mojisola Adeyeye, on Monday.
The agency confirmed that the SMA range marketed in Nigeria is manufactured at Nestlé’s Tuas Factory in Singapore and is duly registered with NAFDAC, including SMA GOLD 1 (NAFDAC Reg. No. B1-2783), SMA GOLD 2 (NAFDAC Reg. No. B1-2780), and SMA GOLD 3 (NAFDAC Reg. No. B1-2781).

You Might Also Like

Nvidia’s board is reportedly ‘not considering’ hiring Jensen

Power Minister Assures Nigerians of Gradual Electricity Restoration as Government Tackles Supply Disruptions

POWER MINISTRY ACKNOWLEDGES ELECTRICITY SUPPLY DISRUPTIONS IN SOME STATES, ASSURES NIGERIANS OF SWIFT RESTORATION

FG Backs Zamfara’s Power Push as Minister Launches State Electricity Policy, Commissions Solar Plants, Breaks Ground for 36 Mini Grids

Rite Foods Breaks into Nigeria’s Top 20 Brands, Climbs to 17th Position in 2026 Ranking

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Nestlé Infant Formula Cleared for Sale in Nigeria — NAFDAC DG
Next Article FG Holds Talks With KPMG Amid Tax Law ‘Error’ Dispute
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

//

We influence 20 million users and we are the number one  news network on the planet

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow
- Advertisement -
Ad imageAd image

Latest News

EU Sanctions Pro-Russian Hacker Group and Propaganda Firm
Press Releases 17 November 2026
Lawyer on the microchip case passcode
Press Releases 17 November 2026
Power Minister Tegbe Reaffirms Tinubu Administration’s Commitment to Improved Electricity Supply
Press Releases 16 November 2026
Promasidor’s Weekly Milk Initiative Brings Fresh Milk to Ikun Pupils, Earns Community and Government Commendation
Press Releases 11 November 2026

Technology

  • Advertise with us
  • Terms & Conditions
  • Privacy Policy

Health

  • Advertise

Entertainment

Sign Up for Our Weeky Newsletter

Subscribe to our weekly newsletter to get our newest article/news/articles instantly!

Phoenix RelationsPhoenix Relations
Follow US
© 2024 Phoenix Relations. | All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?